These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12231529)

  • 41. Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma.
    Zhu XG; Zhao L; Willingham MC; Cheng SY
    Oncogene; 2010 Apr; 29(13):1909-19. PubMed ID: 20062085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomas.
    Sancisi V; Borettini G; Maramotti S; Ragazzi M; Tamagnini I; Nicoli D; Piana S; Ciarrocchi A
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E2006-15. PubMed ID: 22821892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. E-cadherin expression is associated with susceptibility and clinicopathological characteristics of thyroid cancer: A PRISMA-compliant meta-analysis.
    Zhou C; Yang C; Chong D
    Medicine (Baltimore); 2019 Jul; 98(30):e16187. PubMed ID: 31348230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenetic modulators of thyroid cancer.
    Rodríguez-Rodero S; Delgado-Álvarez E; Díaz-Naya L; Martín Nieto A; Menéndez Torre E
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):44-56. PubMed ID: 28440770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.
    Suzuki H; Willingham MC; Cheng SY
    Thyroid; 2002 Nov; 12(11):963-9. PubMed ID: 12490073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma.
    Ying H; Suzuki H; Furumoto H; Walker R; Meltzer P; Willingham MC; Cheng SY
    Carcinogenesis; 2003 Sep; 24(9):1467-79. PubMed ID: 12869418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogen receptors and glucocorticoid receptors in human well-differentiated thyroid cancer.
    Lee C; Kao H; Lin H; P'eng F; Chi C
    Int J Mol Med; 1998 Aug; 2(2):229-233. PubMed ID: 9855694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hereditary non-medullary thyroid cancer.
    Kebebew E
    World J Surg; 2008 May; 32(5):678-82. PubMed ID: 18058169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.
    Schweppe RE; Klopper JP; Korch C; Pugazhenthi U; Benezra M; Knauf JA; Fagin JA; Marlow LA; Copland JA; Smallridge RC; Haugen BR
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4331-41. PubMed ID: 18713817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cell differentiation and local regulatory systems].
    Köhrle J; Jakob F; Jany B; Wilms K
    Internist (Berl); 1995 Apr; 36(4):378-84. PubMed ID: 7775088
    [No Abstract]   [Full Text] [Related]  

  • 51. Misidentification of putative medullary thyroid cancer cell lines RO-H85-1 and RO-D81-1.
    Dadon T; Ball D; Nelkin BD
    J Clin Endocrinol Metab; 2013 Mar; 98(3):954-5. PubMed ID: 23472229
    [No Abstract]   [Full Text] [Related]  

  • 52. Mitochondrial DNA 'common' deletion in Hürthle cell lesions of the thyroid.
    Máximo V; Sobrinho-Simões M
    J Pathol; 2000 Dec; 192(4):561-2. PubMed ID: 11113879
    [No Abstract]   [Full Text] [Related]  

  • 53. Thyroid cancer cell line misidentification: an update.
    Schweppe RE
    J Clin Endocrinol Metab; 2013 Mar; 98(3):956-7. PubMed ID: 23472230
    [No Abstract]   [Full Text] [Related]  

  • 54. [TNM classification--thyroid cancer].
    Fujimori M; Sakauchi G
    Gan No Rinsho; 1967 May; 13(5):320-2. PubMed ID: 5624085
    [No Abstract]   [Full Text] [Related]  

  • 55. Correction for Krieger et al., Mutations in thyroid hormone receptor α1 cause premature neurogenesis and progenitor cell depletion in human cortical development.
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7537-7538. PubMed ID: 32205435
    [No Abstract]   [Full Text] [Related]  

  • 56. Thyroid Hormone Receptor β1 Expression in Developing Mouse Limbs and Face.
    Nagasawa T; Suzuki S; Takeda T; DeGroot LJ
    Endocrinology; 1997 Mar; 138(3):1276-1281. PubMed ID: 28204222
    [No Abstract]   [Full Text] [Related]  

  • 57. Correction: Regulation of cancer stem cell activity by thyroid hormone receptor β.
    Doolittle WKL; Zhu X; Park S; Zhu YJ; Zhao L; Meltzer P; Cheng SY
    Oncogene; 2024 Aug; 43(33):2534. PubMed ID: 39020073
    [No Abstract]   [Full Text] [Related]  

  • 58. Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.
    Piqué DG; Greally JM; Mar JC
    BMC Cancer; 2020 Sep; 20(1):857. PubMed ID: 32894083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Common genetic variants in pituitary-thyroid axis genes and the risk of differentiated thyroid cancer.
    Pastor S; Akdi A; González ER; Castell J; Biarnés J; Marcos R; Velázquez A
    Endocr Connect; 2012 Nov; 1(2):68-77. PubMed ID: 23781307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic features of thyroid hormone receptors.
    Rebaï M; Kallel I; Rebaï A
    J Genet; 2012; 91(3):367-74. PubMed ID: 23271024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.